U.S. FDA approves ViiV Healthcare's Tivicay PD, helping close a critical HIV treatment gap ...
|
FDA ) has approved Tivicay PD (dolutegravir (DTG)), for
use in combination with other antiretroviral agents for the treatment
of HIV-1 infection ... |